C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/1999
12/09/1999	WO1999063346A1 Method and device for electrochemical immunoassay of multiple analytes
12/09/1999	WO1999062919A1 Redox reversible bipyridyl osmium complex conjugates
12/09/1999	WO1999062918A1 Redox reversible imidazole-osmium complex conjugates
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062483A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999	WO1999051720A3 Methods for production of therapeutic cytokines
12/09/1999	CA2333698A1 Pipecolic acid derivative hair growth compositions and uses
12/08/1999	EP0962453A1 Histidine derivatives, process for their preparation and their uses
12/08/1999	EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999	EP0961619A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
12/08/1999	CN1238004A Liquid detergents containing proteolytic enzyme and protease inhibitors
12/08/1999	CN1237978A N (aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds
12/08/1999	CN1047162C Acetylglutaminylzinc compound and its preparation and usage
12/07/1999	US5998470 Osteoporosis; oral diseases; antiarthritic agents
12/07/1999	US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999	US5998436 Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient
12/07/1999	US5998410 Sulfonamide derivatives
12/07/1999	US5998379 Serine protease inhibitors-proline analogs
12/07/1999	US5998378 Compounds having proteolytic inhibitory activity useful for treating diseases, particularly as applied to the treatment of sepsis, aids or autoimmune diseases, resulting from a decrease in the circulating level of mature protein hormones
12/07/1999	US5997933 N-(3,3-dimethylbutyl)-L-aspartyl-D-α-aminoalkanoic acid N-(S)-1-phenyl-1-alkanamide useful as a sweetening agent
12/07/1999	US5997845 Technetium-99M labeled peptides for imaging inflammation
12/02/1999	WO1999061653A2 Light-mediated regional analysis of biologic material
12/02/1999	WO1999061466A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	WO1999061465A1 Phenylalanine derivatives having vla-4 antagonistic activity
12/02/1999	WO1999061431A1 New dipeptidyl peptidase iv effectors
12/02/1999	WO1999061055A1 Bifunctional molecules and therapies based thereon
12/02/1999	WO1999061041A1 Novel peptides
12/02/1999	DE19823831A1 Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen New pharmaceutical use of isoleucyl thiazolidide and its salts
12/02/1999	CA2343317A1 Novel peptides
12/02/1999	CA2332772A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	CA2330611A1 Bifunctional molecules and therapies based thereon
12/01/1999	EP0960886A1 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
12/01/1999	EP0960885A1 Depsipeptides and drugs containing the same as the active ingredient
12/01/1999	EP0960213A1 A METHOD OF DETECTING PROTEIN BY IMMUNO-aRNA
12/01/1999	EP0960122A1 Myelopeptides and their therapeutic use
12/01/1999	EP0960121A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
12/01/1999	EP0582631B1 Use of S-nitrosothiols for the preparation of a medicament for the relaxation of smooth muscle
11/1999
11/30/1999	US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999	US5994391 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
11/30/1999	US5994361 Antitumor, anticancer agent
11/30/1999	US5994312 Peptidyl compounds
11/30/1999	US5994293 Peptidyl compounds and their therapeutic use
11/25/1999	WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999	WO1999059989A1 Process for the preparation of a benzo fused heterocyclo sulfonyl halide intermediate
11/25/1999	WO1999059615A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999	WO1999059526A2 Protease inhibitors
11/25/1999	WO1999047545A3 Inhibitors of caspases
11/25/1999	CA2332531A1 Protease inhibitors
11/25/1999	CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999	CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999	CA2272833A1 Novel histidine derivatives, process for its preparation and uses thereof
11/24/1999	EP0959137A2 Process for the preparation of aspartic acid
11/24/1999	EP0958283A1 New compounds with hemoregulating effect
11/24/1999	CN1236371A Enzymatic method for producing N-formyl-alpha-L-aspartyl-L-phenyalanine methyl ester
11/24/1999	CN1236010A Method for giving resistance to weed control compounds to plants
11/24/1999	CN1046761C Liquid detergents with ortho-substited phenylboronic acids for inhibition of proteolytic enzyme
11/23/1999	US5990341 Diastereoselective synthesis hydroxyethylene dipeptide isosteres
11/23/1999	US5990278 Reacting an organic carboxylic acid with an amine derivative containing a protective group to form protected carbamide, reacting protected carbamide at a first ph to split off protective group, reacting in second ph to form carbamide
11/23/1999	US5990277 Semipeptoid farnesyl protein transferase inhibitors and analogs thereof
11/23/1999	US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity
11/18/1999	WO1999058554A1 Novel aspartame derivative crystal and process for producing the same
11/18/1999	WO1999058553A1 Novel aspartame derivative crystal and process for producing the same
11/18/1999	WO1999058515A1 Novel spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and ap-1 inhibitors containing the same
11/18/1999	WO1999058505A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
11/18/1999	WO1999058140A1 Methods to increase white blood cell survival after chemotherapy
11/18/1999	WO1999057998A1 Novel sweetener compositions
11/18/1999	WO1999057997A1 Sweetener compositions
11/18/1999	WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999	DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999	CA2331998A1 Novel spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and ap-1 inhibitors containing the same
11/18/1999	CA2331819A1 Novel aspartame derivative crystal and process for producing the same
11/18/1999	CA2331810A1 Novel aspartame derivative crystal and process for producing the same
11/18/1999	CA2331295A1 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
11/17/1999	EP0957109A2 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
11/17/1999	EP0957093A2 Retrovial protease inhibitors
11/17/1999	EP0956297A1 Chiral peptide nucleic acids
11/17/1999	EP0956295A1 Process to prepare pharmaceutical compounds
11/17/1999	EP0956294A1 Thrombin inhibitors
11/17/1999	EP0956293A1 Thrombin inhibitors
11/17/1999	EP0956049A2 Conjugates of thrombin inhibitors and endogenes carriers
11/17/1999	EP0956033A1 Total synthesis of the amino hip analogue of didemnin a
11/17/1999	EP0956031A1 Inhibition of 26s and 20s proteasome by indanones
11/17/1999	EP0956029A1 Cyclic peptides having broad spectrum antimicrobial activity
11/17/1999	EP0819135B1 Sugar-modified cytostatics
11/17/1999	EP0697884B1 Ligand precursors for incorporation into peptides
11/17/1999	CN1235610A Peptide derivatives having thiazolyl-alanine residue
11/17/1999	CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999	CN1046537C Preparation of amino acid low peptide
11/17/1999	CN1046525C Compounds containing fused bicyclic ring and preparation thereof
11/17/1999	CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/16/1999	US5986108 Enzyme inhibitors
11/16/1999	US5985935 Treatment and prophylaxis of diseases caused by parasites, or bacteria
11/16/1999	US5985863 Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
11/16/1999	US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999	US5985838 Peptide analogs as irreversible interleukin-1β protease inhibitors
11/16/1999	US5985837 Cell growth inhibitor peptides; treating cancer in a mammal
11/16/1999	US5985632 Peptide amidase from xanthomonas
11/16/1999	US5985292 Active phospholipids as a vector for active molecules
11/16/1999	US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide
11/16/1999	US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis,

1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 307